Navigation Links
Global Analysis of Human DNA Tracks Migration, Identity
Date:2/21/2008

This finding suggests that only a subset of diversity was present in the founding populations of Europe, Bustamante said, adding, "We refer to this as a population bottleneck."

Bustamante's team found that the proportion of mutations that are associated with risk for disease is higher in the European-American population. "This is consistent with evolutionary theory that mutations may undergo slightly relaxed natural selection in bottleneck populations," he said.

All the individuals in the study had about 400 mutations that may be linked to disease, Bustamante said.

How these mutations affect human health isn't known, Bustamante added. "Efforts to do sequencing to look at individuals [with] and without disease will likely find rare mutations that may be contributing to disease," he said.

Last month, it was announced that the genomes of 1,000 people worldwide will be mapped in what scientists are calling the most detailed and medically relevant look at human genetic variation ever conducted.

The 1,000 Genomes Project will receive major support from the U.S. National Human Genome Research Institute (NHGRI), the Wellcome Trust Sanger Institute in England, and the Beijing Genomics Institute in China.

"This new project will increase the sensitivity of disease discovery efforts across the genome fivefold and within gene regions at least 10-fold," NHGRI director Dr. Francis S. Collins said in a prepared statement.

More information

For more information on understanding the human genome, visit the Human Genome Project .



SOURCES: Noah Rosenberg, Ph.D., assistant professor, human genetics, University of Michigan, Ann Arbor; Carlos D. Bustamante, Ph.D., assistant professor, biological statistics and computational biology, Cornell University, Ithaca, N.Y.; Feb.
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named VEGO Power Blocker
2. HOYA ConBio Announces Educational Agreement With LVI Global
3. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
4. Global Med Technologies(R), Inc. Adds Internationally Renowned NewYork- Presbyterian Hospital to Client List
5. Researchers aim to prevent global prematurity and stillbirths
6. Researchers Aim to Prevent Global Prematurity and Stillbirths
7. Large changes needed to address global obesity epidemic
8. Wyeth Consumer Healthcare Names New Head of Global R&D
9. Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM)
10. Global Med Technologies(R), Inc. Recieves FDA 510(K) Clearance for ElDorado Donor(TM)
11. New study shows extent of harmful human influences on global ecosystems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Analysis of Human DNA Tracks Migration, Identity
Global Analysis of Human DNA Tracks Migration, Identity
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 1Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 2Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 1Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 2Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 3Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 4Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 1Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 2Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 3